ICD-10-CM Codes
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
D60-D64 Aplastic and other anemias and other bone marrow failure syndromes
D61- Other aplastic anemias and other bone marrow failure syndromes
2021 ICD-10-CM Diagnosis Code D61.810

2021 ICD-10-CM Diagnosis Code D61.810

Antineoplastic chemotherapy induced pancytopenia

2016

2017

2018

2019

2020

2021

Billable/Specific Code

D61.810 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2021 edition of ICD-10-CM D61.810 became effective on October 1, 2020.
This is the American ICD-10-CM version of D61.810 - other international versions of ICD-10 D61.810 may differ.

Type 2 Excludes

Type 2 Excludes Help

A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (D61.810) and the excluded code together.

aplastic anemia due to antineoplastic chemotherapy (
ICD-10-CM Diagnosis Code D61.1
Drug-induced aplastic anemia
Use Additional
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
D61.1
)

The following code(s) above D61.810 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

Applicable To annotations, or
Code Also annotations, or
Code First annotations, or
Excludes1 annotations, or
Excludes2 annotations, or
Includes annotations, or
Note annotations, or
Use Additional annotations

that may be applicable to D61.810:

D50-D89
2021 ICD-10-CM Range D50-D89
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Type 2 Excludes
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
D61
ICD-10-CM Diagnosis Code D61
Other aplastic anemias and other bone marrow failure syndromes
Type 2 Excludes
- neutropenia (D70.-)
Other aplastic anemias and other bone marrow failure syndromes
D61.81
ICD-10-CM Diagnosis Code D61.81
Pancytopenia
Type 1 Excludes
- pancytopenia (due to) (with) aplastic anemia (D61.9)
- pancytopenia (due to) (with) bone marrow infiltration (D61.82)
- pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01)
- pancytopenia (due to) (with) hairy cell leukemia (C91.4-)
- pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-)
- pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82)
- pancytopenia (due to) (with) myeloproliferative disease (D47.1)
Type 2 Excludes
- pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)
Pancytopenia

Approximate Synonyms

Pancytopenia caused by antineoplastic chemotherapy
Pancytopenia induced by antineoplastic chemotherapy

ICD-10-CM D61.810 is grouped within Diagnostic Related Group(s) (MS-DRG v38.0):

808 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with mcc
809 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with cc
810 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders without cc/mcc

Convert D61.810 to ICD-9-CM

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change

Diagnosis Index entries containing back-references to D61.810:

Pancytopenia (acquired) D61.818
ICD-10-CM Diagnosis Code D61.818
Other pancytopenia
- antineoplastic chemotherapy induced D61.810

ICD-10-CM Codes Adjacent To D61.810

D60.9 Acquired pure red cell aplasia, unspecified

D61 Other aplastic anemias and other bone marrow failure syndromes

D61.0 Constitutional aplastic anemia

D61.01 Constitutional (pure) red blood cell aplasia

D61.09 Other constitutional aplastic anemia

D61.1 Drug-induced aplastic anemia

D61.2 Aplastic anemia due to other external agents

D61.3 Idiopathic aplastic anemia

D61.8 Other specified aplastic anemias and other bone marrow failure syndromes

D61.81 Pancytopenia

D61.810 Antineoplastic chemotherapy induced pancytopenia

D61.811 Other drug-induced pancytopenia

D61.818 Other pancytopenia

D61.82 Myelophthisis

D61.89 Other specified aplastic anemias and other bone marrow failure syndromes

D61.9 Aplastic anemia, unspecified

D62 Acute posthemorrhagic anemia

D63 Anemia in chronic diseases classified elsewhere

D63.0 Anemia in neoplastic disease

D63.1 Anemia in chronic kidney disease

D63.8 Anemia in other chronic diseases classified elsewhere

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

2021 ICD-10-CM Diagnosis Code D61.810

Antineoplastic chemotherapy induced pancytopenia

Drug-induced aplastic anemia

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Other aplastic anemias and other bone marrow failure syndromes

Pancytopenia

Other pancytopenia